Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
Anne-Laure Hemonnot-Girard, Jennifer Hua, Lauriane Ulmann, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 292

Showing 1-25 of 292 citing articles:

Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases
M. Ryan Corces, Anna Shcherbina, Soumya Kundu, et al.
Nature Genetics (2020) Vol. 52, Iss. 11, pp. 1158-1168
Open Access | Times Cited: 296
Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics
Sujata Thakur, Rishika Dhapola, Phulen Sarma, et al.
Inflammation (2022) Vol. 46, Iss. 1, pp. 1-17
Closed Access | Times Cited: 257
Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease
Diane Bairamian, Sha Sha, Nathalie Rolhion, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 202
Blood–Brain Barrier Breakdown: An Emerging Biomarker of Cognitive Impairment in Normal Aging and Dementia
Basharat Hussain, Cheng Fang, Junlei Chang
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 186
Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics
Karthik A. Jagadeesh, Kushal K. Dey, Daniel T. Montoro, et al.
Nature Genetics (2022) Vol. 54, Iss. 10, pp. 1479-1492
Open Access | Times Cited: 145
Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease
Y. Rajesh, Thirumala‐Devi Kanneganti
Cells (2022) Vol. 11, Iss. 12, pp. 1885-1885
Open Access | Times Cited: 142
Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer’s Disease
Grzegorz A. Czapski, Joanna B. Strosznajder
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11677-11677
Open Access | Times Cited: 106
Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation
Giulia Di Benedetto, Chiara Burgaletto, Carlo Maria Bellanca, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2728-2728
Open Access | Times Cited: 83
Stigmasterol attenuates inflammatory response of microglia via NF-κB and NLRP3 signaling by AMPK activation
Jie Fan, Xuan Yang, Bowen Yang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113317-113317
Closed Access | Times Cited: 82
CXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer’s disease pathology
Wei Su, Jordy Saravia, Isabel Risch, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1735-1747
Open Access | Times Cited: 79
Gut bacterial isoamylamine promotes age-related cognitive dysfunction by promoting microglial cell death
Yun Teng, Jingyao Mu, Fangyi Xu, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 7, pp. 944-960.e8
Open Access | Times Cited: 76
PRSet: Pathway-based polygenic risk score analyses and software
Shing Wan Choi, Judit García‐González, Yunfeng Ruan, et al.
PLoS Genetics (2023) Vol. 19, Iss. 2, pp. e1010624-e1010624
Open Access | Times Cited: 65
TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease
Yueran Li, Huifang Xu, Huifang Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115218-115218
Open Access | Times Cited: 47
Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models
Laura Sebastián Monasor, Stephan A. Müller, Alessio Colombo, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 111
Current Advances in The Development of Novel Polymeric Nanoparticles for The Treatment of Neurodegenerative Diseases
Amanda Cano, Elena Sánchez‐López, Miren Ettcheto, et al.
Nanomedicine (2020) Vol. 15, Iss. 12, pp. 1239-1261
Open Access | Times Cited: 108
The role of innate immunity in Alzheimer's disease
Hannah E. Ennerfelt, John R. Lukens
Immunological Reviews (2020) Vol. 297, Iss. 1, pp. 225-246
Open Access | Times Cited: 94
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
Amanda Cano, Patric Turowski, Miren Ettcheto, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 86
Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's disease
Jielin Xu, Pengyue Zhang, Yin Huang, et al.
Genome Research (2021) Vol. 31, Iss. 10, pp. 1900-1912
Open Access | Times Cited: 67
Microvascular Alterations in Alzheimer's Disease
Joe Steinman, Hong‐Shuo Sun, Zhong‐Ping Feng
Frontiers in Cellular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 61
Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases
Nima Javanmehr, Kiarash Saleki, Parsa Alijanizadeh, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 59
Evolutionary conservation and divergence of the human brain transcriptome
William G. Pembroke, Christopher Hartl, Daniel H. Geschwind
Genome biology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 57
Inflammasome activation in traumatic brain injury and Alzheimer's disease
Nathan H. Johnson, Juan Pablo de Rivero Vaccari, Helen M. Bramlett, et al.
Translational research (2022) Vol. 254, pp. 1-12
Open Access | Times Cited: 51
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 46
Adoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer's disease
Hyejin Yang, Seon‐Young Park, Hyunjung Baek, et al.
Theranostics (2022) Vol. 12, Iss. 18, pp. 7668-7680
Open Access | Times Cited: 39
Microglia-containing cerebral organoids derived from induced pluripotent stem cells for the study of neurological diseases
Yiling Hong, Dong Xu, Lawrence Chang, et al.
iScience (2023) Vol. 26, Iss. 3, pp. 106267-106267
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top